title: Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: american society of clinical oncology endorsement of the college of american pathologists/international association for the study of lung cancer/association for molecular pathology guideline.
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY; Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Natasha
authors.initials: N
authors.lastname: Rekhtman
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY; Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Natasha B
authors.initials: NB
authors.lastname: Leighl
authors.affiliation: Memorial Sloan Kettering Cancer Center, New York, NY; Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Somerfield
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D008495:Medical Oncology; D010338:Pathology, Clinical; D057089:Pathology, Molecular; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics*; D012955:Societies, Medical; D014481:United States
chemical_list: D047428:Protein Kinase Inhibitors; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; C512478:EGFR protein, human; D066246:ErbB Receptors; D020794:Receptor Protein-Tyrosine Kinases